echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Where and why proteins malfunction in Parkinson's disease

    Where and why proteins malfunction in Parkinson's disease

    • Last Update: 2022-09-07
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Scientists from the Francis Crick Institute at UCL and the University of Edinburgh have discovered how a harmful protein starts to build up in neurons in Parkinson's disease, eventually causing the nerve cells to die


    Parkinson's is a progressive neurodegenerative disease that causes tremors, slowed movement, stiffness, and can progress to severe cognitive problems


    Parkinson's disease is caused by the loss of neurons in specific parts of the brain


    In their paper published Aug.


    Using neurons derived from cells donated by people with the genetic form of Parkinson's and healthy individuals, the team was able to visualize where, why and how the protein began to misfold and accumulate within nerve cells


    The interdisciplinary team of neuroscientists, chemists and structural biologists discovered that alpha-synuclein contacts the membrane, or lining, of structures within nerve cells


    A large number of proteins then accumulate on the surface of the mitochondria, damaging the surface of the mitochondria, causing pores to form in the membrane and interfering with the mitochondria's ability to create energy


    While there are multiple subtypes of Parkinson's, the protein is known to misfold and clump together in all subtypes


    Sonia Gandhi, lead author and senior group leader at Crick University and Professor of Neurology at UCL's Queen Square Institute of Neurology, said: "Great progress has been made in understanding protein misfolding, but major challenges remain is the first stage in studying this process in human cells


    "Our study provides insights into what happens in the earliest stages of protein misfolding and how they affect cell health


    Andrey Abramov, professor at the Queen's Square Institute of Neurology at UCL, added: "We have known for some time that mitochondria are abnormal in Parkinson's disease, but the reasons for this have not been clear


    Lead author Minee Choi, a senior postdoctoral researcher at the University of the Crick, said: "Our study used neurons derived from cells from Parkinson's patients, which means that the neurons we studied have the same genetic makeup and characteristics


    Matthew Horrocks, co-lead author and Senior Lecturer in Biophysical Chemistry at the University of Edinburgh, added: "We have been able to use a range of state-of-the-art biophysical techniques to study how proteins misfold and cause damage in extremely complex biological samples, which is very impressive.


    The innovative new method developed by the researchers can also be used to study protein misfolding in other neurodegenerative diseases and cell types, including glial cells involved in neurodegenerative diseases


    The team will continue their work to study how protein misfolding within cells affects cell function and health


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.